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Abstract
This paper will review the current role of general practitioners
(GPs) in providing cardiovascular prevention for patients after atten-
dance at a cardiac rehabilitation program. Long-term implementation
of preventive strategies is needed for continued impact on reducing
risk of cardiovascular events and GPs have a major role in providing
ongoing continuing medical care. Awareness of patients’ social, cul-
tural and physical circumstances allows the GP to identify individuals’
needs for support in engaging in secondary prevention: relevant brief
interventions can promote behaviour change in physical activity, diet
and smoking habits, as well as promoting mental health and adher-
ence to optimal medical therapy. Collaborative multidisciplinary
working with community and hospital services provides best opportu-
nities for timely referral to specialist expertise to maximise patients’
well-being. 
Cardiac rehabilitation and the general practitioner 
General practitioners (GPs), together with other healthcare profes-
sionals working within primary care, have an important role in en-
couraging patients to maintain and further develop the health gains de-
rived from cardiac rehabilitation (CR) programs. GPs carry responsi-
bility for ensuring that, in the longer-term, after a cardiovascular diag-
nosis or acute event, medication for secondary prevention is prescribed
appropriately and that cardiovascular risk factors are monitored and
minimised. Also, GPs are frequently involved in consultations con-
cerning the early diagnosis and ongoing management of other ill-
nesses and are often aware of particular circumstances existing within
family and social networks. Thus, they are ideally placed to encourage
ongoing adherence to secondary prevention following CR and to pro-
mote healthy lifestyle behaviour in a way that is relevant to the indi-
vidual, their social setting and their cultural environment. 
A health professional’s communication of their perception of the im-
portance of CR to patients is an important factor in encouraging atten-
dance [1,2] and their endorsement of an invitation to CR increases its
likelihood of uptake [2,3]. Furthermore, patients appreciate having ex-
pert and practical advice provided by a trusted physician [4]. GPs will
have knowledge of their patients’ participation or non-participation in
CR programs following a new cardiac diagnosis, event or intervention,
so that they have an important role in advocating the value of CR and
maintenance of implementation of its core components [5]. 
It is appropriate for the GP to explore reasons why patients may not
participate in CR and to determine how a program may be made avail-
able, accessible and acceptable to them [6,7]. Some may not have been
invited to participate in a program; for others, hospital and group based
sessions may not be accessible or acceptable because of barriers such
as lack of transport, inconvenient timing, social responsibilities or per-
sonal embarrassment [7]. For these, the GP may identify suitable
home-based CR programs [8,9] or relevant community based initia-
tives that are based on principles of comprehensive CR and promote
secondary prevention [10]. 
General practice and cardiovascular disease
prevention
The GP has a role in both secondary and primary prevention of car-
diovascular disease and should have clearly established links with the
preventive services which may be based in hospital or the community,
for their optimal delivery and avoidance of unnecessary duplication.
They should ensure that patients understand advice given to them
within CR programs and identify ongoing support for implementation
of that advice and the achievement and maintenance of healthy
lifestyles. 
Health professionals who themselves have healthier lifestyle habits
are more likely to counsel their patients about their lifestyles and to
feel more confident in doing so [11]. Evidence indicates that those
who are more physically active are more likely to educate their patients
about physical activity and to motivate their patients to become more
physically active [12]. Patients’ perceptions of their GP’s health status
influences their perceptions of advice given about healthy eating and
exercise: they often feel more confident about advice received from a
GP whom they perceive as being healthy and are more likely to put that
advice into practice [13].
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Smoking cessation
Smoking cessation is a key goal during and after CR [5]. Brief ad-
vice given by a physician has a positive effect on smoking cessation,
increasing an unassisted quit rate by 1% - 3% [21]. The approach of
‘5 A’s’, asking patients about their smoking habit, advising of the
benefits of stopping, assessing their motivation to stop, assisting
them in stopping and arranging a follow-up appointment to review
progress, is recommended [22]. Assistance can be provided on an
individual or group basis, face-to-face or using electronic communi-
cation systems and with or without pharmacotherapy [23]. Pharma-
cotherapy could include nicotine replacement therapy (NRT),
varenicline or bupropion, prescribed with planned and agreed re-
view intervals. Patients should be assisted to set an appropriate
‘stop date’ and plan for what to do if they fail. Social support for
stopping may also be found among friends and family or within com-
munity based services.
In addition to referring or ‘signposting’ patients to cessation support
services, GPs have a role in being an advocate for ‘no smoking’ public
legislation and promoting no-smoking policies within local communi-
ties [24]. When social contacts smoke and fail to appreciate the ad-
verse impact of smoking on health, this places barriers to patients’ suc-
cess in stopping smoking [4]. A no-smoking ‘norm’ within the social
network of their family and community will encourage the adoption and
maintenance of non-smoking behaviour. 
Physical activity
GPs should provide active encouragement for patients to achieve
recommended daily levels of physical activity across all population sub-
groups [25]. Identifying patients who are physically inactive and pro-
viding brief advice with possible referral to community-based walking
or cycling programs or exercise schemes may support patients’ en-
gagement in physical activity. The cost-effectiveness of exercise re-
ferral schemes is uncertain [26] but community based walking pro-
grams and individual pedometer-based programs in general practice
can be low cost and effective, both for the general population [27] and
those who have participated in CR [28].
Clear guidance has been given for professionals who are involved in
advising patients with cardiovascular disease regarding appropriate
levels of physical activity for their health benefit [5]. GPs have a role
in ensuring that patients have access to easy to read fact sheets, such
as are available on the internet, so that they understand what is meant
by recommendations regarding activities of varying intensity [29].
However, behaviour change requires not only the necessary knowledge
and psychological and physical capacity to perform the behaviour but
also requires opportunities to make it possible within an individual’s
physical, social and cultural environment [30]. Thus, strategies which
seek to motivate individuals to change behaviours should ensure that
they provide access to information that is clearly understood and access
to the best possible conditions to promote uptake of advice. 
The likelihood of patients with cardiovascular disease maintaining
or increasing the level of physical activity they achieved during CR pro-
grams is greater if they live within a society that encourages physical
activity. Behaviour change is difficult and whilst people are supported
in making positive changes by positive social influences, they are also
adversely influenced by peers, family and friends who advocate and en-
gage in unhealthy behaviours [4]. A systematic review of interventions
to promote physical activity in socioeconomically disadvantaged com-
munities [31] found that group-based interventions had a positive im-
pact on physical activity levels for adults and that interventions which
provided a mix of professional guidance and on-going practical support
were most likely to be effective [32]. 
Modifiable risk factors for cardiovascular diseases include not only
physical inactivity and dietary factors but also smoking, excessive al-
cohol, hypertension, dyslipidaemia, diabetes, and obesity. These are ad-
dressed within comprehensive CR programs [5]; GPs contribute to
their continued modification in lifelong secondary prevention. 
Secondary prevention in general practice 
A structured approach to the provision of secondary prevention
leads to improved processes of care, including prescription of appro-
priate medication, and improved outcomes, including risk factor con-
trol [14], all-cause mortality and recurrent myocardial infarction
[15]. In general practice, the organisation of regular recall of pa-
tients with established cardiovascular disease to review their health
status, risk factors and medication, and to provide lifestyle advice, is
effective in reducing patients’ symptoms and improving their bio-
physical risk factor control and their diet and physical activity habits
[16,17]. 
A recent systematic review confirmed an approximate 20% reduc-
tion in all-cause mortality and 26% reduction in risk of cardiac-related
death in patients with cardiovascular disease who received structured
programs of secondary prevention in primary care or community set-
tings, compared to usual care [18]. However, evidence of a ‘ceiling ef-
fect’ was noted, whereby the additional effect of a specific organisa-
tional intervention on improving risk factor management is dimin-
ished when usual care is of high quality and follows similar principles
of structured review. This was postulated as an explanation of the
failure of a more recent intervention, that provided general practices
with tailored management plans, to show benefit in risk factor control,
although it was associated with a significant reduction in hospital ad-
missions [19]. Of note, the effectiveness of interventions to improve
the delivery of secondary prevention in general practice tend to di-
minish after the intervention ends [18], highlighting the need to em-
phasise that GPs should maintain focused attention on the structure
of their plans for providing this care. 
Different healthcare systems may facilitate the organisation of sec-
ondary prevention in different ways but it is worthwhile noting that the
measurement and good control of biophysical risk factors does not
alone necessarily maximise patients’ well-being and quality of life. A
comparative study of two different healthcare systems found that whilst
risk factor control was better in one, which incentivised annual reviews
of patients with cardiovascular disease by GPs, the diet and physical ac-
tivity habits and quality of life of patients in the other system, with un-
structured care provision, were better [20]. GPs should have good
knowledge of their patients’ family and social circumstances, with
awareness of barriers to their optimal reduction in cardiovascular risk.
Using this knowledge should facilitate the implementation of compre-
hensive secondary prevention [5], with maximal well-being, for all
their patients. 
Promoting healthy lifestyle behaviours
Whilst time for consultation with individual patients in general prac-
tice is limited, and intensive counselling may not be possible or prac-
tical, there is evidence for the effectiveness of brief interventions in
promoting lifestyle change. It is important that GPs identify the dif-
ferent aspects of individuals’ lifestyles which may be associated with
cardiovascular risk so that they deliver relevant brief advice and offer
onward referral to other professionals within the primary care team,
community based services or hospital, as appropriate. 
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GPs have a role in advising patients, in supporting community based
initiatives, in alerting their patients to their availability and in advo-
cacy with local agencies to ensure that the design and implementation
of these initiatives are tailored to local context and community needs,
including those of patients with cardiovascular disease. They also have
a responsibility to recognise that patients are more likely to feel confi-
dent about their advice and follow it if they themselves are perceived to
be healthy and physically active [12,13].
Healthy eating
Healthy eating advice relevant to both the primary and secondary
prevention of cardiovascular disease is focused on the ‘Mediterranean
diet’, with increased consumption of fish, fruit, raw and cooked veg-
etables and olive oil [33,34]. Clinicians should routinely advise their
patients to continue to adopt this approach to nutrition after comple-
tion of their CR program, in order to achieve lifelong optimal disease
prevention. The provision of simple advice such as this after myocar-
dial infarction has been associated with an increased frequency of con-
sumption of these foods and a protective effect: higher levels of con-
sumption of these foods were associated with a substantial reduction
in the risk of early death [35].
In some communities barriers to complying with this advice may be
a lack of availability of fresh fruit or vegetables or a cultural context
that promotes eating ‘fast foods’. Again GPs have a role in trying to en-
sure that the health education messages that are disseminated within
CR, as well as via public health campaigns, are understood and relevant
to the local community. The optimal provision of healthcare is de-
pendent on the collaborative interaction of multiple sectors of society
and GPs should endeavour to work with policymakers and community
leaders to reduce barriers, such as lack of food availability, cost and
cooking habits, making the ‘healthier choice’ the ‘easier choice’ [36].
The value of social support for behavioural change in diet is recognised
[4]. Secondary prevention programs which have included patients’
family members or friends in planning management of cardiovascular
risk reduction have shown good results in respect of improved dietary
habits [37]. 
Mental health
Psychological distress, anxiety and depression are common
amongst patients with cardiovascular disease, including those who
have just completed CR programs [38]. In the ongoing monitoring of
these patients’ progress it is important for GPs to be alert to the po-
tential diagnosis of depression. Asking patients if they have been
bothered by feeling ‘down, depressed or hopeless’ or by having ‘little
interest or pleasure in doing things’ are useful screening questions
[39] which can be further explored with relevant validated clinical
questionnaires [40]. 
The diagnosis of coronary heart disease and, in turn, its treatments
may evoke stress [41] and lead to depression and the development of
posttraumatic stress disorder. The impact of these conditions on pa-
tients’ partners is important, as partners have the potential to affect pa-
tients’ responses to their diagnosis and management [42]. GPs are
uniquely placed to be aware of medical and psycho-social problems af-
fecting family members and may alleviate these, reducing stress for
both patients and their partners, by giving opportunity for fears to be
revealed and discussed and for questions to be asked and answered to
allow clear understanding and reassurance.
Patients with cardiovascular disease and depression are at increased
risk of adverse outcomes [38]. Identifying and treating depression can
be a major challenge as patients often have difficulty communicating
problems with their mental health to others. Management options in
general practice include provision of general health advice, coun-
selling, on an individual or group basis, with cognitive-behavioural
therapy, and anti-depressant medication [38]. Including partners or
‘significant others’ in management plans can help to ensure effective
social support to address concerns and motivate healthy lifestyle
habits. If there is no response to initial therapies, then options include
referral for advice from specialist secondary care providers. 
Sexual activity
Patients are often concerned about resuming sexual relations fol-
lowing a vascular diagnosis or event but may be too embarrassed to
voice these concerns to health professionals. GPs who are aware of
their patients’ social circumstances may be pro-active in raising the
issue, may help identify reasons for problems, including side-effects of
medication, and provide reassurance regarding the safety of resump-
tion of sexual activity, in accordance with guidance [33,43]. If GPs do
not feel comfortable discussing this topic, they should adopt a non-
judgemental approach and signpost patients to appropriate resources,
such as family planning or sexual health clinics. 
Alcohol consumption
In response to stress, such as that associated with a cardiac event or
diagnosis, some patients’ consumption of alcohol may increase, or may
be maintained at higher levels than recommended, with increased risk
of further cardiovascular events. In general practice these individuals
may be identified by using a validated alcohol screening questionnaire,
such as The Alcohol-use disorders identification test (AUDIT) [44], of
which an abbreviated version is available (‘AUDIT-C’). GPs can offer a
brief intervention using the ‘FRAMES’ principles (Feedback, Responsi-
bility, Advice, Menu, Empathy, Self-efficacy) [45]. These include dis-
cussion of potential harm caused by drinking, reasons for changing be-
haviour, barriers to change and practical strategies to help, for ex-
ample, setting specific goals. Such discussion may prevent develop-
ment of adverse consequences. Patients who require more intensive
interventions for problematic alcohol consumption can be signposted to
appropriate services, such as community addiction teams, for specialist
input.
Pharmacological management
Guidelines for the management of stable coronary heart disease in-
clude guidance regarding appropriate drug prescription [46]. They pro-
vide information about the appropriate targets for control of risk factors
and the prescription of anti-platelet therapy, statins, beta-blockers and
anti-hypertensive medications, as well as nitrates and other drugs for
the control of symptoms. Prescribing guidelines in respect of specific
first preference drugs may vary nationally and with time but GPs have
a responsibility to be aware of these and to ensure that best practice in
prescribing is adhered to for each individual patient. For example, one
large observational study of patients with acute myocardial infarction
found that only about half were discharged with optimal medical
therapy compared with the standards in guidelines [47] and there is
evidence that prescribing of secondary prevention medication across
many European countries is suboptimal [48]. The GP has an important
role in checking that patients receive appropriate medication prescrip-
tion after CR and that they are fully involved in decision-making about
prescribed medicines.
Patients should be aware of why they are taking specific medica-
tion, how to take it, its proposed benefits, potential side-effects and
relevant cautions to be exercised when taking it. These discussions
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can be supported by appropriate written information, giving patients
time to read and ask questions, making further appointments as nec-
essary to ensure clear understanding and reach a well-informed
shared decision about taking it. It is estimated that one third to a half
of all medicines prescribed for long-term cardiovascular conditions are
not taken as prescribed [49]. GPs can promote medication adherence
by recommending the use of ‘drug diaries’, ensuring that the drug
regime is clear, offering simple solutions to side-effects, encouraging
the use of using containers that aid compliance and suggesting self-
monitoring, for example, of blood pressure, to provide feedback re-
garding risk factor control. 
Collaborative working
An understanding of barriers which adversely influence motivation
to follow healthy lifestyle advice and engage in secondary prevention is
important. GPs are well placed to identify how preventive strategies can
best be tailored to their patients’ needs and to facilitate collaborative
working between multidisciplinary professionals based in the commu-
nity, primary care and hospital. New methods of exchanging informa-
tion electronically between those involved in a patient’s care are being
developed and many will depend on the GP’s contribution to co-ordi-
nated teamwork. Integrated primary and secondary preventive care, in-
volving patients and their families [50], based on a model of nurse-led
multidisciplinary preventive cardiology [37] has shown improved
lifestyle habits and better control of risk factors in both patients and
their partners. GPs have an important role to play in ensuring that the
provision of secondary cardiovascular disease prevention for their pa-
tients is optimal and maintained in the long-term, after attendance at
cardiac rehabilitation.
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